Related Experiment Video
Updated: Jun 17, 2026

Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses
Published on: January 20, 2017
Mucosal Taï Forest virus infection causes disease in ferrets
Paige Fletcher1, Kyle L O'Donnell1, Joseph F Rhoderick1
1Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, United States of America.
Ferrets infected with Taï Forest virus (TAFV) via mucosal routes developed severe disease, unlike intramuscular exposure. Mucosal TAFV infection in ferrets may offer cross-protection against Ebola virus (EBOV).
Area of Science:
- Virology
- Infectious Diseases
- Animal Models
Background:
- Taï Forest virus (TAFV) is a filovirus that has caused human infections.
- Natural filovirus exposure likely occurs via mucosal routes, but animal models typically use intramuscular (IM) inoculation.
- Developing a TAFV ferret model using mucosal exposure is crucial for understanding pathogenicity.
Purpose of the Study:
- To develop and characterize a ferret disease model for TAFV infection via intramuscular (IM), intranasal (IN), and aerosol routes.
- To assess the potential cross-protection between TAFV and Ebola virus (EBOV) in ferrets.
Main Methods:
- Ferrets were inoculated with TAFV via IM, IN, or aerosol routes.
- Survivors of TAFV infection were rechallenged with EBOV via IM or IN routes.
- Disease severity, lethality, and protective effects were monitored.
Main Results:
- Intranasal and aerosol TAFV inoculation caused moderate to severe disease and partial lethality in ferrets, while IM inoculation resulted in minimal signs.
- Only ferrets that were intranasally inoculated with TAFV and subsequently intranasally inoculated with EBOV were protected from disease.
- Other ferrets succumbed to EBOV infection after rechallenge, indicating limited cross-protection.
Conclusions:
- Ferrets are a suitable animal model for assessing TAFV pathogenicity, particularly via mucosal exposure routes.
- Mucosal exposure to TAFV may induce cross-protection against EBOV, but this effect appears route-dependent.
Related Concept Videos
Poliomyelitis
Rabies
Cytomegalovirus Disease

